Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

belotecan

Known as: 7-(2-(N-isopropylamino)ethyl)camptothecin 
The active ingredient in a substance being studied in the treatment of small cell lung cancer and other types of cancer. It blocks certain enzymes… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The prognosis of patients diagnosed with glioblastoma remains dismal in spite of the current concomitant chemoradiotherapy with… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Belotecan (Camtobell, CKD602) is a new camptothecin derivative antitumor agent that belongs to the topoisomerase inhibitors. The… Expand
Is this relevant?
2010
2010
BACKGROUND The objective of this study was to investigate the efficacy of belotecan, a new camptothecin analog, combined with… Expand
Is this relevant?
2010
2010
Belotecan (Camtobell, CKD602) is a new camptothecin derivative antitumor agent that belongs to the topoisomerase inhibitors. The… Expand
Is this relevant?
2010
2010
This study evaluated the efficacy and toxicity of belotecan (CKD-602), a new camptothecin analogue topoisomerase i inhibitor, in… Expand
Is this relevant?
2009
2009
OBJECTIVE This study was performed to determine the safety and efficacy of belotecan, a new camptothecin analogue and potent… Expand
Is this relevant?
2008
2008
PurposeTo investigate the underlying mechanism of low bioavailabilities of the water-soluble camptothecin derivatives, belotecan… Expand
  • figure 1
  • figure 2
  • table I
  • table II
  • figure 4
Is this relevant?
2008
2008
BACKGROUND Belotecan (Camtobell, Chong Keun Dang Corp, Seoul, Korea; CKD602) is a new camptothecin analogue. This study aimed to… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
2007
2007
Purpose: Belotecan (Camtobell, CKD602) is a novel camptothecin derivative. This study was designed to determine the maximum… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2006
2006
PURPOSE We wanted to demonstrate the anti-cancer effect and interaction between belotecan and cisplatin on gastric cancer cell… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?